Response rates of various treatments for extranodal nasal-type NK/T-cell lymphoma in children and adolescents
. | Total no. . | CR, no. (%) . | PR, no. (%) . | SD, no. (%) . | PD, no. (%) . |
---|---|---|---|---|---|
All patients, n = 37 | |||||
Response after initial therapy | |||||
RT | 19 | 14 (73.7) | 1 (5.3) | 1 (5.3) | 3 (15.8) |
CT | 18 | 3 (16.7) | 10 (55.6) | 2 (11.1) | 3 (16.7) |
Response after therapy | |||||
RT alone | 9 | 9 (100) | 0 (0) | 0 (0) | 0 (0) |
RT + CT | 10 | 7 (70.0) | 0 (0) | 0 (0) | 3 (30.0) |
CT + RT ± CT | 18 | 16 (88.9) | 1 (5.5) | 0 (0) | 1 (5.5) |
Total | 37 | 32 (86.5) | 1 (2.7) | 0 (0) | 4 (10.8) |
Stages I and II, n = 33 | |||||
Response after initial therapy | |||||
RT | 19 | 14 (73.7) | 1 (5.3) | 1 (5.3) | 3 (15.8) |
CT | 14 | 3 (21.4) | 6 (42.9) | 2 (14.3) | 3 (21.4) |
Response after therapy | |||||
RT alone | 9 | 9 (100) | 0 (0) | 0 (0) | 0 (0) |
RT + CT | 10 | 7 (70.0) | 0 (0) | 0 (0) | 3 (30.0) |
CT + RT ± CT | 14 | 13 (92.9) | 0 (0) | 0 (0) | 1 (7.1) |
Total | 33 | 29 (87.9) | 0 (0) | 0 (0) | 4 (12.1) |
. | Total no. . | CR, no. (%) . | PR, no. (%) . | SD, no. (%) . | PD, no. (%) . |
---|---|---|---|---|---|
All patients, n = 37 | |||||
Response after initial therapy | |||||
RT | 19 | 14 (73.7) | 1 (5.3) | 1 (5.3) | 3 (15.8) |
CT | 18 | 3 (16.7) | 10 (55.6) | 2 (11.1) | 3 (16.7) |
Response after therapy | |||||
RT alone | 9 | 9 (100) | 0 (0) | 0 (0) | 0 (0) |
RT + CT | 10 | 7 (70.0) | 0 (0) | 0 (0) | 3 (30.0) |
CT + RT ± CT | 18 | 16 (88.9) | 1 (5.5) | 0 (0) | 1 (5.5) |
Total | 37 | 32 (86.5) | 1 (2.7) | 0 (0) | 4 (10.8) |
Stages I and II, n = 33 | |||||
Response after initial therapy | |||||
RT | 19 | 14 (73.7) | 1 (5.3) | 1 (5.3) | 3 (15.8) |
CT | 14 | 3 (21.4) | 6 (42.9) | 2 (14.3) | 3 (21.4) |
Response after therapy | |||||
RT alone | 9 | 9 (100) | 0 (0) | 0 (0) | 0 (0) |
RT + CT | 10 | 7 (70.0) | 0 (0) | 0 (0) | 3 (30.0) |
CT + RT ± CT | 14 | 13 (92.9) | 0 (0) | 0 (0) | 1 (7.1) |
Total | 33 | 29 (87.9) | 0 (0) | 0 (0) | 4 (12.1) |
RT indicates radiotherapy; CT, chemotherapy; CR, complete remission; PR, partial remission; SD, stable disease; and PD, progressive disease.